American Society of Hirudotherapy

Achieving Textbook Outcomes in Bilateral DIEP Flap Breast Reconstruction: Does a Co-Surgeon Matter?

Retrospective study with propensity score matching published in Journal of reconstructive microsurgery (2025)

Last Updated: November 1, 2026ASH Editorial · based on the books
Research article — evidence review: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Article reference: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.
Evidence: Observational studyClinical LiteratureDeVito et al. · Journal of reconstructive microsurgery, 2026

Abstract

BACKGROUND: It is essential to examine predictors of ideal outcomes in surgery. "Textbook outcomes" are optimal surgical results based on multiple quality measures. It is important that patients have access to trusted centers that consistently produce high-quality surgical outcomes. METHODS: A retrospective review of all bilateral Deep Inferior Epigastric Perforator (DIEP) flap breast reconstructions at our institution from 2017 to 2022 was performed. Criteria for "textbook outcome" were operating room (OR) time within one standard deviation of institutional average or less, length of stay ≤ 4 days, no intraoperative complications, no operative complications, no readmission within 30 days, no infection requiring IV antibiotics, no systemic complications, and no mortality. Propensity score matching was used to control for common comorbidities, reconstruction timing, and oncologic factors. This resulted in 47 matched pairs of bilateral DIEP flap reconstructions for comparison between a single-surgeon cohort and a co-surgeon cohort. RESULTS: Textbook outcomes occurred at a significantly higher rate in the co-surgeon cohort compared with the single surgeon cohort (79% vs. 57%, p = 0.025). The average OR time was significantly shorter in the co-surgeon cohort compared with the single surgeon cohort (403 minutes vs. 572 minutes, p < 0.0001), and elevated OR time was the most common reason for not achieving a textbook outcome. There were no differences in the other criteria for a "textbook outcome." CONCLUSION: Textbook outcomes in bilateral DIEP flap breast reconstruction are achieved at significantly higher rates with a co-surgeon. This is primarily due to significantly shorter OR times. Further research into factors affecting textbook outcomes is needed.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeComparative StudyJournal Article
Indexed MeSH termsRetrospective StudiesOperative TimeLength of StayTreatment OutcomeMammaplastyPropensity ScoreHumansMaleFemaleMiddle AgedOutcome Assessment, Health CareSurgeonsPerforator FlapEpigastric ArteriesPostoperative Complications

Summary

In 47 propensity-matched pairs of bilateral DIEP flap breast reconstructions, textbook outcomes were achieved more often with a co-surgeon (79% vs 57%), driven mainly by shorter operating times (403 vs 572 minutes); other criteria did not differ.

Context

This retrospective review used propensity-score matching to compare 47 pairs of bilateral DIEP flap breast reconstructions performed by a single surgeon versus a co-surgeon team. It found higher 'textbook outcome' rates in the co-surgeon cohort (79% vs. 57%, p = 0.025), mainly due to shorter average operating-room time (403 vs. 572 minutes, p < 0.0001), with no significant differences in the other measured criteria. The study addresses surgical-team configuration and operative efficiency in autologous breast reconstruction. The abstract does not mention leeches, hirudotherapy, flap salvage for venous congestion, or the leech secretome.

Citation

Reference (Vancouver style)

DeVito RG, Newson C, Ke BG, Yang H, Pawly J, Hollenbeck ST, et al. Achieving Textbook Outcomes in Bilateral DIEP Flap Breast Reconstruction: Does a Co-Surgeon Matter? J Reconstr Microsurg. 2026;42(5):427-432. doi:10.1055/a-2671-8578. PMID: 40744102

Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.

Added to ASH library: May 28, 2026 · Site last updated: November 1, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.